TNF and COVID-19: Recently, Saleh et al. [32] reported that the A allele of the TNF G-308 A promoter variant (rs1800629) is associated with a more aggressive COVID-19 pattern, and authors suggested that the use of anti-TNF therapy may be promising in those patients.